Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Hidradenitis Suppurativa and Treatments
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the treatment, pathogenesis, and comorbidities of Hidradenitis Suppurativa (HS), also known as Acne Inversa. It covers topics such as inflammatory pathways, genetic susceptibility, metabolic syndrome, and the impact of HS on quality of life. The cluster also discusses various therapeutic approaches including immunosuppressive therapy and TNF-alpha inhibitors.
86
Works
IDs:OpenAlex
How has Hidradenitis Suppurativa and Treatments's publication output changed over time?
ScholarIQpublication output · 2014–2023
Output grew0% over the shown period — from 1 works in 2014 to 1 in 2023.
1
4
2
2
1
1
3
1
20142015201620172018201920202023
What are the most-cited papers on Hidradenitis Suppurativa and Treatments?
ScholarIQmost cited works
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Alexa B. Kimball, Martin M. Okun, David Williams, Alice B. Gottlieb, Kim Papp, Christos C. Zouboulis, April W. Armstrong, Francisco A. Kerdel, Michael H. Gold, Seth Forman, Neil J. Korman, Evangelos J. Giamarellos‐Bourboulis, Jeffrey Crowley, Charles Lynde, Z. Reguiaï, Errol-Prospero Prens, Eihab Alwawi, Nael M. Mostafa, Brett Pinsky, Murali Sundaram, Yihua Gu, Dawn M. Carlson, Gregor B. E. Jemec
New England Journal of Medicine. 2016790 Citations
Hidradenitis suppurativa
Robert Sabat, Gregor B. E. Jemec, Łukasz Matusiak, Alexa B. Kimball, Errol P. Prens, Kerstin Wolk
Nature Reviews Disease Primers. 2020566 Citations
Hidradenitis suppurativa
Samantha R. Goldburg, Bruce Strober, Michael Payette
S58727509. 2019476 Citations
Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity
Christos C. Zouboulis, Thrasyvoulos Tzellos, Αthanassios Kyrgidis, Gregor B. E. Jemec, Falk G. Bechara, Evangelos J. Giamarellos‐Bourboulis, John R Ingram, Theodora Kanni, Ioannis Karagiannidis, Antonio Martorell, Łukasz Matusiak, Andreas Pinter, Errol P. Prens, Dagmar Presser, Sylke Schneider‐Burrus, Esther von Stebut, Jacek C. Szepietowski, Hessel H. van der Zee, Sophia Wilden, Robert Sabat, Rodney Sinclair, Dunja Ana Vekic, P. De Haes, V. del Mármol, Afsáneh Alavi, Wayne Gulliver, Aude Nassif, Georgios Nikolakis, Maurizio Podda, C. Antoniou, Florentina Delli, Clio Dessinioti, Aikaterini Patsatsi, Anastasia Trigoni, C. Zisimou, Vincenzo Bettoli, Simone Garcovich, Jurr Boer, Barbara Horváth, G. Ingvarsson, L. Puig, Robert E. Hunger, Lennart Emtestam, F. William Danby, Alexa B. Kimball
British Journal of Dermatology. 2017466 CitationsOPEN ACCESS
Diagnostic delay in hidradenitis suppurativa is a global problem
Ditte Marie Lindhardt Saunte, Jurr Boer, Alexander Stratigos, Jacek C. Szepietowski, Iltefat Hamzavi, K.H. Kim, Kian Zarchi, C. Antoniou, Łukasz Matusiak, Henry W. Lim, Melissa Williams, Hayoung Kwon, MA Gürer, F. Mammadova, A Kaminsky, Errol P. Prens, Hessel H. van der Zee, Vincenzo Bettoli, Stefania Zauli, Jürg Hafner, Severin Läuchli, Lars E. French, Hassan Riad, Moetaz El‐Domyati, Hossam Abdel‐Wahab, Brian Kirby, G. Kelly, Perla Calderón, V. del Mármol, Farida Benhadou, J. Revuz, Christos C. Zouboulis, Ioannis Karagiannidis, Karin Sartorius, Lena Hagströmer, Erin McMeniman, Nicholas Wei Xun Ong, Mateja Dolenc‐Voljč, Zrinka Bukvić Mokoš, Luca Borradori, Robert E. Hunger, Christopher Sladden, Noah Scheinfeld, Nayera Moftah, Lennart Emtestam, Jan Lapins, N. Doss, Ichiro Kurokawa, Gregor B. E. Jemec
British Journal of Dermatology. 2015392 CitationsOPEN ACCESS
Where is Hidradenitis Suppurativa and Treatments research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
S58727509476
S135397728374
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Hidradenitis Suppurativa and Treatments is open access?
ScholarIQopen access share
53%OPEN ACCESS
Gold
7%
Green
7%
Hybrid
20%
Bronze
20%
Closed
47%
Related on ScholarIQ
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
Paper
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Paper
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Paper
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Paper
Hidradenitis suppurativa
Paper
Obesity and the skin: Skin physiology and skin manifestations of obesity
Paper